3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Esophageal Neoplasms
1
Disease
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
2040
Radiotherapy
1854
Cisplatin
1820
Carboplatin
1530
Gemcitabine
1432
Paclitaxel
1289
Bevacizumab
1267
Docetaxel
1200
pembrolizumab
1196
Oxaliplatin
1157
Capecitabine
1140
Fluorouracil
1059
Dexamethasone
971
Rituximab
918
Nivolumab
908
Magnetic Resonance Spectroscopy
858
Etoposide
839
Doxorubicin
823
Drug Therapy
789
Radiosurgery
774
Irinotecan
774
Cytarabine
736
fludarabine
714
Leucovorin
674
Lenalidomide
608
fludarabine phosphate
564
Temozolomide
552
Filgrastim
540
Radiation
539
Cetuximab
535
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Patient Positioning
×
Clear all
NCT02865239
2018-08-08
EFIMED
Institut de Cancérologie de Lorraine
Phase NA
Completed
15 enrolled
NCT02157363
2017-10-20
POETRI
Technische Universität Dresden
Phase NA
Terminated
47 enrolled